Home›Psychiatry› VRET Reduces PTSD Symptoms in Military Veterans
VRET Reduces PTSD Symptoms in Military VeteransVirtual Reality Therapy Shows Promise for Veterans with PTSD
Frontiers in MedicinePublished August 9, 2026DOI ↗Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
VRET significantly reduces PTSD symptoms in veterans, but its advantage over control conditions is modest.
A meta-analysis of 444 military veterans with PTSD examined the effects of Virtual Reality Exposure Therapy (VRET) on symptom severity. The analysis included studies comparing pre- and post-treatment scores as well as VRET versus control conditions.
Within-group comparisons showed marked reductions in PTSD symptoms. Clinician-administered CAPS scores dropped by a pooled mean difference of 33.73 (95% CI: 7.80 to 59.65), and self-reported PCL scores decreased by 20.96 (95% CI: 13.05 to 28.86). These findings suggest substantial improvement after VRET.
However, when VRET was compared directly to control conditions, the effects were smaller and not always statistically significant. For CAPS, the pooled mean difference was 4.86 (95% CI: -8.34 to 18.07), and for PCL, it was 1.93 (95% CI: -0.02 to 3.89). This indicates that VRET may offer only modest benefits over non-VR interventions.
Combining both types of comparisons, the overall effect favored VRET, with a mean difference of 23.26 for CAPS (95% CI: 8.00 to 38.52) and 13.66 for PCL (95% CI: 5.00 to 22.31). These results were statistically significant, supporting VRET's potential as a treatment option.
Limitations include high heterogeneity across studies and small sample sizes in some trials, which may affect the reliability of the findings. The authors note that definitive conclusions about comparative efficacy and long-term benefits are limited. Nonetheless, VRET appears to be a promising approach for reducing PTSD symptoms in veterans, potentially improving engagement and reducing dropout rates.
How this fits prior evidence
This meta-analysis addresses the need for effective interventions for PTSD symptoms, building upon evidence that various interventions can reduce mental health symptoms in populations affected by extreme weather events. While this study specifically focuses on military veterans using VRET technology, it adds to the body of evidence regarding non-pharmacological treatments for PTSD.
Researchers looked at a group of 444 military veterans to see how Virtual Reality Exposure Therapy (VRET) affects Post-Traumatic Stress Disorder (PTSD). This type of treatment uses virtual environments to help people face and process traumatic memories. The study compared these results against standard control conditions.
The findings showed that participants who used VRET saw a marked reduction in their symptom severity scores when comparing their progress from start to finish. When comparing the therapy directly to other methods, the improvements were more modest but still showed statistically significant benefits for those using virtual reality.
Because this was a meta-analysis of several different studies, there is some uncertainty. Some individual studies had small numbers of participants, and the results varied between different types of VR setups. While VRET shows promise for reducing symptoms and potentially keeping patients more engaged in treatment, it is still early to know how well it works over many years or how it compares perfectly to every other available option.
What this means for you:
Virtual reality therapy may help reduce PTSD symptoms in veterans, though results vary across different study types.
Common questions
Is Virtual Reality Exposure Therapy effective for PTSD?
The study found that VRET led to a marked reduction in the severity of PTSD symptoms when comparing patients' progress from start to finish. While the direct comparison between VRET and other control conditions showed more modest effects, the overall results still favored the use of virtual reality for those suffering from PTSD.
Who specifically was studied in this research?
The study included 444 military veterans. The focus was on measuring their symptoms using two specific scales: the Clinician-Administered PTSD Scale (CAPS) and the PTSD Checklist (PCL). These tools help doctors track how much a person's symptoms improve during treatment.
Are there any risks or side effects to this treatment?
The provided data did not report any specific adverse events, serious incidents, or issues with how well patients tolerated the therapy. However, because some studies were small and varied in their methods, you should talk to a doctor to understand how this treatment fits your specific needs.
This systematic review and meta-analysis evaluated the effectiveness of Virtual Reality Exposure Therapy (VRET) for treating Post-Traumatic Stress Disorder (PTSD) in military veterans. A comprehensive search of electronic databases identified 9 randomized controlled trials involving 444 veterans that met inclusion criteria. The primary outcomes were changes in PTSD symptom severity measured by the Clinician-Administered PTSD Scale (CAPS) and PTSD Checklist (PCL). The meta-analysis demonstrated significant reductions in PTSD symptom severity in pre–post comparisons following VRET. In contrast, comparisons between VRET and control conditions showed smaller and more variable effects, highlighting the importance of cautious interpretation when assessing comparative efficacy. The pooled mean difference in CAPS scores was 33.73 (95% CI: 7.80 to 59.65) for pre-post comparisons, indicating a marked reduction in symptom severity following treatment. For PCL scores, the pooled mean difference was 20.96 (95% CI: 13.05 to 28.86). When compared to controlled conditions, VRET was associated with modest effects, with a pooled mean difference of 4.86 (95% CI: -8.34 to 18.07) for CAPS scores and 1.93 (95% CI: - 0.02 to 3.89) for PCL scores. Overall, combining pre-post and controlled comparisons yielded statistically significant effects favoring VRET, with mean differences of 23.26 (95% CI: 8.00 to 38.52) for CAPS and 13.66 (95% CI: 5.00 to 22.31) for PCL scores. However, high heterogeneity was observed across studies, warranting cautious interpretation. Risk of bias assessment indicated low to moderate risk of bias across the included studies. Visual inspection of funnel plots suggested no strong asymmetry; however, interpretation is limited due to the small number of studies included. These findings suggest that VRET may be an effective intervention for reducing PTSD symptoms in military veterans, particularly in within-group analyses, although comparative effects relative to control conditions were more modest. The immersive features of VRET may offer an alternative means of delivering exposure-based interventions, although patient acceptability and clinical utility likely vary across individuals and settings. VRET shows promise as an alternative or adjunct to conventional treatments, potentially improving engagement and reducing dropout rates. However, small sample sizes in some studies and heterogeneity of results limit definitive conclusions. Further large-scale trials are needed to establish VRET’s comparative efficacy and long-term benefits in military populations.Aim: To systematically review and meta-analyze the efficacy of virtual reality-based exposure therapy (VR-ET) for treating post-traumatic stress disorder (PTSD) in military veterans.Objectives: To evaluate the efficacy of VR-based exposure therapy in reducing PTSD symptoms and achieving remission among military veterans. 2. To compare the efficacy of different VR protocols, such as: Immersive vs. non-immersive systems, Combat-related vs. non-combat trauma scenarios 3. To explore heterogeneity in treatment outcomes based on: Veteran-specific factors (e.g., age, service duration, comorbidities)Study characteristics (e.g., sample size, design, control group) 4. To identify barriers to implementation of VR-based exposure therapy in veteran healthcare systems, including: Cost and resource availability, Technological literacy among patients and providers, Logistical and infrastructural limitationsSystematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251207784, identifier CRD420251207784.
